4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-019950
Options or other derivatives
- EVP, Research and Development acquired 409,704 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Knappertz Volker EVP, Research and Development | 2022-08-01 | Grant or award · Stock Option (right to buy) | +256,892 | 256,892 | D | ||
| Knappertz Volker EVP, Research and Development | 2022-08-01 | Grant or award · Restricted Stock Units | +152,812 | 152,812 | D | ||
Loading xslF345X03/wf-form4_165938480733710.xml…